Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity - Frontiers in Endocrinology Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity - JAMA Internal Medicine Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes - New England Journal of Medicine Tirzepatide for Diabetes Improves Glycemic Control After Switch From GLP-1RA - Endocrinology Advisor Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension - Diabetes, Obesity and Metabolism
The bundle option Replenza offers both products together as the Replenza Duo Bundle
This product should only be handled by licensed and qualified professionals
For reference purposes, here is a sample liraglutide dosing protocol for weight loss research [35, 36]: Liraglutide Dose: Start with 0.6mg/daily in week one, followed by an increase to 1.2mg/daily in week two, 1.8mg/daily in week three, 2.4mg/daily in week four, and 3.0mg/daily in weeks five and beyond
